雷迪帕韦中间体2
时间:2015-09-25 12:56:50 作者:admin
 

CAS No.: 1441670-89-8;

纯度 ≥ 98%


Ledipasvir is a drug for the treatment of hepatitis C. And the ledipasvir/sofosbuvir combination is a direct-acting antiviral agent that interferes with HCV replication and can be used to treat patients with genotypes 1a or 1b without PEG-interferon or ribavirin.

 

 
 

All Rights Reserved 2015-2020 Xiamen Halosyntech Co., Ltd 闽ICP备15020441号-1
Tel:0592-6688068 Address: Unit 404/block5,120 Xinyuan RD,Haicang District,Xiamen,PRC